Home Home Home Inbox Home Search

Event

Improvements in Exacerbation Rate and Lung Function with Weight-Based Intravenous Reslizumab Dosing in Patients with Baseline High Body Weight [Board No. P881]

Location: Board no. P881
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Mirna McDonald

Ms
Teva Pharmaceuticals

Margaret C. Garin

MD
Teva Pharmaceuticals

Kevin R. Murphy

MD
Boys Town National Research Hospital

View Abstract

Improvements in Exacerbation Rate and Lung Function with Weight-Based Intravenous Reslizumab Dosing in Patients with Baseline High Body Weight

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search